Genomictree Balance Sheet Health
Financial Health criteria checks 4/6
Genomictree has a total shareholder equity of ₩129.0B and total debt of ₩1.8B, which brings its debt-to-equity ratio to 1.4%. Its total assets and total liabilities are ₩136.9B and ₩7.9B respectively.
Key information
1.4%
Debt to equity ratio
₩1.83b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩99.36b |
| Equity | ₩129.00b |
| Total liabilities | ₩7.90b |
| Total assets | ₩136.90b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: A228760's short term assets (₩101.4B) exceed its short term liabilities (₩5.0B).
Long Term Liabilities: A228760's short term assets (₩101.4B) exceed its long term liabilities (₩2.9B).
Debt to Equity History and Analysis
Debt Level: A228760 has more cash than its total debt.
Reducing Debt: A228760's debt to equity ratio has increased from 1% to 1.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A228760 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if A228760 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.